Early skeletal muscle loss during target therapy is a prognostic biomarker in metastatic renal cell carcinoma patients.
about
Early skeletal muscle loss during target therapy is a prognostic biomarker in metastatic renal cell carcinoma patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Early skeletal muscle loss dur ...... renal cell carcinoma patients.
@en
type
label
Early skeletal muscle loss dur ...... renal cell carcinoma patients.
@en
prefLabel
Early skeletal muscle loss dur ...... renal cell carcinoma patients.
@en
P2093
P2860
P1433
P1476
Early skeletal muscle loss dur ...... renal cell carcinoma patients
@en
P2093
Dingwei Ye
Guohai Shi
Hailiang Zhang
Junlong Wu
Xiaohang Liu
P2860
P2888
P356
10.1038/S41598-017-07955-6
P407
P50
P577
2017-08-08T00:00:00Z
P6179
1091025351